NPPB and cardiomyopathy: Routine baseline NT-proBNP measurements could therefore serve to detect those cirrhotic patients with unrecognised cardiomyopathy, as suggested by Sheer et al. [22], where serum NT-proBNP levels > 1000 pg/mL reliably distinguished between ascites due to CCF or cirrhosis.